Contributions of contact activation pathways of coagulation factor XII in plasma

被引:27
作者
Chatterjee, Kaushik [2 ]
Guo, Zhe
Vogle, Erwin A. [3 ,4 ]
Siedlecki, Christopher A. [1 ,2 ]
机构
[1] Penn State Univ, Milton S Hershey Med Ctr, Dept Surg, Inst Biomed Engn,Coll Med, Hershey, PA 17033 USA
[2] Penn State Univ, Dept Bioengn, Coll Med, Hershey, PA 17033 USA
[3] Penn State Univ, Dept Bioengn, University Pk, PA 16802 USA
[4] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA
基金
美国国家卫生研究院;
关键词
coagulation; blood compatibility; Hageman factor; plasma proteins; HUMAN HAGEMAN-FACTOR; BLOOD-COAGULATION; HYDROPHOBIC SURFACES; AUTOACTIVATION; COMPATIBILITY; CASCADE;
D O I
10.1002/jbm.a.32076
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Activation of human blood plasma coagulation by contact with hydrophilic or hydrophobic surfaces (procoagulants) is dominated by kallikrein (Kal)-mediated activation of the blood zymogen FXII (Hageman Factor). Mathematical modeling of prekallikrein (PK)-deficient platelet-poor plasma (d(PK)PPP) and PK-reconstituted d(PK)PPP (Rd(PK)PPP) coagulation shows that autoactivation of FXII (FXII ->(surface) FXIIa) produces no more than about 25% of the total FXIIa produced by the intrinsic pathway. Autoactivation mid reciprocal-activation increase, in the same proportion with procoagulant surface energy (water-wettability), whereas total amount of FXIIa produced per-unit-area procoagulant remains roughly constant for any particular procoagulant. These results suggest that procoagulant surfaces initiate the intrinsic cascade by producing a bolus of FXIIa in production to surface energy or surface area but play no additional role in subsequent molecular events in the cascade. Results further suggest that reciprocal-activation occurs in proportion to the amount of FXIIa produced by the initiating autoactivation step. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 27-34, 2009
引用
收藏
页码:27 / 34
页数:8
相关论文
共 25 条
[1]  
ANDRADE JD, 1981, T AM SOC ART INT ORG, V27, P659
[2]   Procoagulant activity of surface-immobilized Hageman factor [J].
Chatterjee, Kaushik ;
Vogler, Erwin A. ;
Siedlecki, Christopher A. .
BIOMATERIALS, 2006, 27 (33) :5643-5650
[3]  
COLMAN RW, 2001, PRINCIPLES CLIN PRAC, P103
[4]  
Davie E W, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P277
[5]   The fibrinolysis system: Regulation of activity and physiologic functions of its main components [J].
Dobrovolsky, AB ;
Titaeva, EV .
BIOCHEMISTRY-MOSCOW, 2002, 67 (01) :99-108
[6]  
DUNN JT, 1982, J BIOL CHEM, V257, P1779
[7]  
GALLOWAY AC, 1999, PRINCIPLES SURG, P845
[9]  
GRIFFIN JH, 1979, SEMIN THROMB HEMOST, V5, P254
[10]   Mathematical modeling of material-induced blood plasma coagulation [J].
Guo, Z ;
Bussard, KM ;
Chatterjee, K ;
Miller, R ;
Vogler, EA ;
Siedlecki, CA .
BIOMATERIALS, 2006, 27 (05) :796-806